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Background
Enhanced responsiveness of the vascular smooth muscle
cell to vasoconstrictor stimuli has been described in insu-
lin-resistant states. Fructose overload leads to the develop-
ment of the metabolic syndrome and its associated
cardiovascular disorders including hypertension. We pos-
tulated that chronic treatment with sildenafil would regu-
late the abnormally increased pressor response to a
norepinephrine challenge in fructose-fed rats. Material
and methods Wistar rats were fed a standard chow
(CONT, n = 12) or a 60% fructose-enriched diet contain-
ing 5% fat (% by weight) for 8 weeks (FFR, n = 12). From
week 5 through 8, sildenafil (twice a day sc, 20 mg/kg)
was administered (FFR+SIL, n = 14), thus reaching clini-
cally relevant plasma concentrations circa 20 nM
unbound (Pfizer Inc., data on file), followed by a 1-week
wash-out period (W9). On W9, in a sub-group of these
conscious rats (n = 5) that had previously been implanted
with telemetric devices, AP was recorded following cumu-
lative infusion of noradrenaline (NA 50, 100, 200, 400
ng/kg/min). In all rats, urinary 8-isoprostane (IPT) and
TxB2 levels were determined during a 24-hour period. Tis-
sue ET-1 content was measured in segments of aortic and
mesenteric artery.
Results
Fasting glycemia was unchanged in all rats while triglycer-
idemia were elevated in FFR compared to CONT (2.0 ± 0.4
mM vs 1.2 ± 0.2, p < 0.05) and corrected by sildenafil
treatment (1.3 ± 0.2, NS vs CONT). Resting AP was similar
in all rats. Pressor responses to NA were exacerbated in
FFR (maximal increase from basal MAP: +22.8 ± 1.7 vs
+38.0 ± 7.3 mmHg, respectively, p < 0.05) and normal-
ized by sildenafil treatment (+24.9 ± 5.2 mmHg, NS vs
CONT). Vascular ET-1 levels were not modified by the
fructose nor sildenafil treatment whereas the increased
production of urinary IPT and TxB2 in FFR versus CONT
(2.07 ± 0.36 ng/ml/24 h vs 0.88 ± 0.13 and 12.86 ± 1.91
pg/ml/24 h vs 7.25 ± 0.59, respectively, p < 0.05) were
corrected following sildenafil treatment (0.95 ± 0.14 ng/
ml/24 h and 8.74 ± 1.06 pg/ml/24 h, respectively, NS vs
CONT).
Conclusion
In FFR, pressor responses to NA were potentiated, suggest-
ing enhanced responsiveness of the vascular smooth mus-
cle cell to vasoconstrictor stimuli. Chronic treatment with
sildenafil was able to normalize the hemodynamic
response to norepinephrine while restoring normal excre-
tion of urinary biological markers of oxidative stress and
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vasoactive mediators in FFR. Both IPT and TxB2 could be
considered as surrogate markers of endothelial function
in clinical trials addressing cardiovascular risks.
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